Molecular Confirmation of Vancomycin-Resistant Staphylococcus aureus with vanA Gene from a Hospital in Kathmandu

Meera Maharjan1, Anil Kumar Sah2, Susil Pyakurel3

  • 1Department of Microbiology, Kantipur College of Medical Science, Sitapaila, Kathmandu, Nepal.

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is a major health concern. This study found a significant rate of vancomycin-resistant S. aureus (VRSA) and identified the vanA gene in some isolates, highlighting the need for surveillance.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Staphylococcus aureus is a common cause of nosocomial infections.
  • Methicillin-resistant S. aureus (MRSA) poses a significant global health threat.
  • Vancomycin is the primary treatment for MRSA, but resistance is emerging.

Purpose of the Study:

  • To determine the prevalence of vancomycin-resistant S. aureus (VRSA).
  • To detect vancomycin resistance genes (vanA and vanB) in S. aureus isolates.
  • To assess antibiotic susceptibility patterns in a hospital setting in Nepal.

Main Methods:

  • Hospital-based cross-sectional study conducted from July to December 2018.
  • Isolation and identification of S. aureus from clinical samples.
  • Antibiotic susceptibility testing using Kirby-Bauer disc diffusion and MIC.
  • MRSA screening via CLSI guidelines and VRSA confirmation using E-test strips.
  • Detection of vanA and vanB genes by conventional polymerase chain reaction (PCR).

Main Results:

  • A total of 74 S. aureus isolates were obtained, with 60.81% identified as MRSA.
  • Five isolates (11.11%) were confirmed as VRSA.
  • Two VRSA isolates (40%) tested positive for the vanA gene.
  • Linezolid demonstrated effectiveness, while 89.2% of isolates were resistant to penicillin.
  • The majority of S. aureus isolates (93.2%) exhibited a multidrug resistance (MAR) index > 0.2.

Conclusions:

  • The study highlights a significant prevalence of MRSA and a concerning rate of VRSA in the studied hospital.
  • The presence of the vanA gene in VRSA isolates warrants attention.
  • Routine surveillance for MRSA and VRSA is recommended in hospital settings to guide empirical therapy.

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...